^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

miR-155 expression

i
Other names: MIR155, MicroRNA 155, MIRN155
Entrez ID:
Related biomarkers:
7d
Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line. (PubMed, Talanta)
We highlighted the ability of MB to detect changes in the target gene expression after gene silencing. Overall, this innovative approach represents a promising tool for detecting various biomarkers at the same time, with potential applications in clinical settings.
Preclinical • Journal
|
MIR155 (MicroRNA 155)
|
miR-155 expression
8d
Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer. (PubMed, Int J Colorectal Dis)
Radical surgery reduces the levels of serum miR-21-5p, miR-135-5p, and miR-155-5p expression in patients with CRC. The use of Bifidobacterium triplex viable capsules assists in achieving quicker perioperative recovery from radical surgery in CRC patients, and this underlying mechanism may be associated with the regulation of serum miR-21-5p, miR-135-5p, and miR-155-5p expression levels.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21)
|
miR-155 expression
15d
Biochemical Significance of miR-155 and miR-375 as Diagnostic Biomarkers and Their Correlation with the NF-κβ/TNF-α Axis in Breast Cancer. (PubMed, Indian J Clin Biochem)
Additionally, the signaling of TNF-alpha and NF-κβ were found to be significantly upregulated in the serum of patients with breast cancer. Up-regulation of miR-155 and miR-375 expression may be diagnostic biomarkers of breast cancer, pointing to the role of NF-κβ and TNF-α expression in miR-155 and miR-375 expression as therapeutic targets of breast cancer in the future.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MIR155 (MicroRNA 155) • MIR375 (MicroRNA 375)
|
miR-155 expression • miR-375 expression
17d
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes. (PubMed, Transl Oncol)
In addition, ROC curves were performed to assess the sensitivity and specificity of different combinations of these miRNAs, confirming a high diagnostic accuracy for LUSC of up to 88 % in male subjects. The expression levels in tissue samples and the abundance in plasma and plasma EVs of the three miRNAs combined - miR-21-5p, miR-155-5p and miR-181a-5p - could be considered for further studies on biomarkers for the early detection of LUSC in male subjects.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR181A1 (MicroRNA 181a-1)
|
miR-155 expression
19d
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study. (PubMed, Int J Mol Sci)
Moreover, miR-155 expression correlated with the focus score (FS), as well as BAFF-R and IL-6R expression, which were increased in primary Sjögren's disease patients and in turn related to neoplastic evolution. In conclusion, epigenetic modulation may play a crucial role in the aberrant activation of B-cells in primary Sjögren's disease, profoundly impacting the risk of NHL development.
Journal
|
MIR155 (MicroRNA 155) • IL6R (Interleukin 6 receptor)
|
miR-155 expression • IL6 expression • TNFRSF13C expression
23d
Lifestyle-Driven Variations in Nutrimiromic MicroRNA Expression Patterns across and beyond Genders. (PubMed, Life (Basel))
In conclusion, the study underscores the significant influence of lifestyle, nutrition, and sex on miRNA profiles. Circulating miRNAs demonstrate significant potential as biomarkers in personalized medicine, highlighting their utility in tailoring healthcare to individual needs.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR328 (MicroRNA 328)
|
miR-155 expression
23d
Analysis of Primary Chronic Lymphocytic Leukemia Cells' Signaling Pathways. (PubMed, Biomedicines)
In addition, miR-15a, miR-181, and miR-146 were decreased and miR-155 had increased expression in most samples. The activation of the NOTCH pathway in vitro increases the susceptibility of primary CLL cells to apoptosis despite high BCL2 expression.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • NOTCH1 (Notch 1) • IKZF1 (IKAROS Family Zinc Finger 1) • MIR155 (MicroRNA 155) • HES1 • MIR15A (MicroRNA 15a)
|
BCL2 expression • NOTCH1 expression • miR-155 expression
27d
The role of miR-155 in urologic malignancies. (PubMed, Biomed Pharmacother)
This article provides a comprehensive review of the significant role played by miR-155 in the development of urologic malignancies. Furthermore, the potential of miR-155 as a biomarker and therapeutic target in urologic malignancies is also discussed.
Review • Journal
|
MIR155 (MicroRNA 155)
|
miR-155 expression
1m
Protective Effects of Aspirin Supplemented With Quercetin in L-NAME-Induced Preeclampsia-Like Rats. (PubMed, Physiol Res)
The decreased miR-155 level in placenta further increased the protein level of SOCS1 and inhibited the phosphorylation of p65. In this study, we demonstrated that aspirin supplemented with quercetin enhanced the effects of aspirin for the treatment of preeclampsia.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • MIR155 (MicroRNA 155) • SOCS1 (Suppressor Of Cytokine Signaling 1)
|
miR-155 expression
1m
Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia (clinicaltrials.gov)
P1, N=30, Active, not recruiting, City of Hope Medical Center | Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Dec 2023 --> Dec 2024
Trial completion date • Trial primary completion date • Combination therapy
|
MIR155 (MicroRNA 155) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1)
|
miR-155 expression • NFKB1 expression
|
decitabine • pevonedistat (MLN4924)
1m
The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients. (PubMed, Cell Mol Biol (Noisy-le-grand))
In conclusion, the present study demonstrated that the Cell Rich TM system combined with the negative enrichment strategy can effectively detect CTCs in the peripheral blood of gastric cancer patients and that the expression of miR-96 can be used as an effective indicator to predict CTC status and assist in determining the prognosis of gastric cancer. These findings have important implications for the diagnosis and treatment of gastric cancer and provide new clues for the further study of the tumor immune microenvironment and tumor heterogeneity.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • CDH1 (Cadherin 1) • MIR155 (MicroRNA 155) • VIM (Vimentin) • MIR96 (MicroRNA 96) • MIR223 (MicroRNA 223) • MIR370 (MicroRNA 370) • MIR409 (MicroRNA 409) • MIR1207 (MicroRNA 1207) • MIR148A (MicroRNA 148a) • MIR149 (MicroRNA 149) • MIR218 (MicroRNA 218)
|
miR-155 expression • miR-96 expression
2ms
Detection of MicroRNAs Using Synthetic Toehold Switch in Mammalian Cells. (PubMed, Methods Mol Biol)
Here, we designed a novel synthetic toehold switch for detection of exogenously and endogenously expressed miRNAs in CHO, HeLa, HEK 293, and MDA-MB-231 breast cancer cells. Multiplex detection of miR-155 and miR-21 was tested using two toehold switches to evaluate the orthogonality and programmability of this synthetic platform.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21)
|
miR-155 expression
2ms
Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance. (PubMed, Int J Mol Sci)
One recent study found that the upregulation of miR-145 and the downregulation of miR-155 strongly correlated with a limited chemotherapy resistance to Cisplatin, 5-Fluorouracil, and Paclitaxel, although the mechanism(s) responsible for these observations remain unidentified. The potential involvement of these targets must be further investigated to determine how and whether mechanisms of these cellular pathways may be involved in the observed lack of chemotherapy resistance. These data may be important to design targets or treatments to reduce chemotherapy resistance and improve patient treatment outcomes.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR125 (MicroRNA 125) • MIR152 (MicroRNA 152) • MIR221 (MicroRNA 221) • FSCN1 (Fascin Actin-Bundling Protein 1) • MIR1246 (MicroRNA 1246) • MIR140 (MicroRNA 140) • MIR145 (MicroRNA 145) • MIR218 (MicroRNA 218) • MIR224 (MicroRNA 224)
|
miR-155 expression
|
cisplatin • paclitaxel • 5-fluorouracil
2ms
Curcumin mediated dendritic cell maturation by modulating cancer associated fibroblasts-derived exosomal miRNA-146a. (PubMed, J Cancer Res Ther)
Collectively, these findings provide insight into understanding the immunomodulatory role of curcumin in targeting CAFs and modulating TME, thus enhancing antitumor immune response in DC based therapy.
Journal • IO biomarker
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4) • MIR155 (MicroRNA 155) • IL10 (Interleukin 10) • TGFB1 (Transforming Growth Factor Beta 1) • MIR142 (MicroRNA 142) • MIR221 (MicroRNA 221) • CD80 (CD80 Molecule) • CD86 (CD86 Molecule) • MIR222 (MicroRNA 222)
|
miR-155 expression • CTLA4 expression • IL6 expression • miR-221 expression
2ms
Ferroptosis-related genes, a novel therapeutic target for focal segmental glomerulosclerosis. (PubMed, BMC Nephrol)
Finally, 75 drugs targeting 54 important circRNAs and FRGs were predicted. This study identified the Hub FRGs and transcriptomic molecules from FSGS in renal tubules, thus providing novel diagnostic and therapeutic targets for FSGS.
Journal
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • MIR155 (MicroRNA 155) • ATF3 (Activating Transcription Factor 3) • DUSP1 (Dual Specificity Phosphatase 1) • JUN (Jun proto-oncogene) • MIR124-2 (MicroRNA 124-2) • MIR124-3 (MicroRNA 124-3)
|
miR-155 expression • HIF1A expression
2ms
A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma. (PubMed, Curr Mol Med)
Despite the promising properties of RSV in inhibiting hepatitis-related HCC cell proliferation, its antiviral effects in viral hepatitis are controversial. The antihepatitis behaviors of RSV are mainly dose-dependent, and in some studies, activating some hepatoprotective pathways increases the transcription and replication of chronic HBV and HCV. Therefore, healthcare providers should be aware of viral hepatitis before using RSV supplements.
Review • Journal
|
mTOR (Mechanistic target of rapamycin kinase) • CCND1 (Cyclin D1) • MIR155 (MicroRNA 155)
|
CCND1 expression • miR-155 expression
2ms
High-throughput RNA sequencing identifies the miRNA expression profile, target genes, and molecular pathways contributing to growth of sporadic vestibular schwannomas. (PubMed, Acta Neurochir (Wien))
We identified a set of 9 miRNAs that are significantly deregulated in large VS in comparison to small, intracanalicular tumors. The functional enrichment analysis of these miRNAs suggests novel mechanisms, such as that lipid metabolism, as well as Hippo and FOxO signaling pathways that may play an important role in VS growth regulation.
Journal
|
CCND1 (Cyclin D1) • MIR155 (MicroRNA 155) • MIR142 (MicroRNA 142) • MIR7 (MicroRNA 7) • JARID2 (Jumonji And AT-Rich Interaction Domain Containing 2) • MIR1269A (MicroRNA 1269a) • MIR4664 (MicroRNA 4664) • LMNB2 (Lamin B2) • MIR204 (MicroRNA 204) • MIR342 (MicroRNA 342)
|
miR-155 expression
2ms
Vitamin D and miRNA-155 in Behçet's Disease: Possible Association with the Disease and Disease Activity. (PubMed, Rep Biochem Mol Biol)
Vitamin D relative expression is significantly low in BD patients, which can significantly influence immunomodulatory BD therapy. Vitamin D deficiency linked to active BD.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MIR155 (MicroRNA 155)
|
miR-155 expression
2ms
microRNAs expression profile in phyllodes tumors of the breast. (PubMed, Heliyon)
We reported that miR-34a, miR-148a and miR-205 were downregulated in both borderline and malignant PTs compared to fibroadenoma and normal tissue. In silico miRNA target prediction suggested the involvement of these molecules in a wide context of cell signaling pathways.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR34A (MicroRNA 34a-5p) • MIR182 (MicroRNA 182) • MIR148A (MicroRNA 148a) • MIR205 (MicroRNA 205)
|
miR-155 expression
3ms
Dysregulation of miRNA expression in patients with chronic myelogenous leukemia at diagnosis: a systematic review. (PubMed, Biomark Med)
Among them, miR-21 and miR-155 were identified as the most common miRNAs with increased expression and miR-150 and miR-146 as the most common miRNAs with decreased expression. miRNAs can be used as an indicator for the early detection and treatment of CML phase.
Review • Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR150 (MicroRNA 150)
|
miR-155 expression
3ms
Correlation of miR-155-5p, KRAS, and CREB Expression in Patients with Acute Myeloid Leukemia. (PubMed, Clin Lab)
Our study revealed that miR-155 and CREB had overexpression compared to the control group.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • MIR155 (MicroRNA 155)
|
miR-155 expression • KRAS expression
3ms
Co-treatment of silymarin and cisplatin inhibited cell proliferation, induced apoptosis in ovarian cancer. (PubMed, Mol Biol Rep)
Based on our findings, SLM boosts the anticancer activity of Cis and mitigates its side effects. Thus, the co-treatment of SLM and Cis can be proposed as a promising therapeutic strategy for further investigation.
Journal
|
MIR155 (MicroRNA 155) • MIR27A (MicroRNA 27a)
|
miR-155 expression
|
cisplatin
3ms
Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome. (PubMed, Pathol Res Pract)
miR-21 can be utilized as a sensitive biomarker for childhood NB development. In pediatric NB, miR-21 was linked to intermediate monocyte plasticity. Both, miR-21 and miR-155 had no impact on NB outcome.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21)
|
miR-155 expression
3ms
miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. (PubMed, Oncol Lett)
Higher expression levels of let-7c-5p, miR-106b-5p, miR-26a-5p, miR-155-5p, miR-191-5p, miR-30b-5p and miR-31-5p were significantly associated with a good prednisone response...The change in expression levels between diagnosis and the end of induction differed significantly between risk groups for three miRNAs: miR-206, miR-210 and miR-99a (P=0.033, P=0.047 and P=0.008, respectively), with the post induction levels of miR-206 increased in high-risk patients, whilst miR-210 and miR-99a levels were increased in intermediate/standard risk patients. Therefore, miRNAs that could be integrated into the risk stratification of pediatric ALL after further evaluation in larger patient cohorts were identified.
Journal
|
MIR155 (MicroRNA 155) • MIR30B (MicroRNA 30b) • Let-7c (MicroRNA Let-7c) • MIR206 (MicroRNA 206) • MIR210 (MicroRNA 210) • MIR31 (MicroRNA 31) • MIR99A (MicroRNA 99a) • MIR106B (MicroRNA 106b) • MIR150 (MicroRNA 150) • MIR191 (MicroRNA 191) • MIR26A1 (MicroRNA 26a-1)
|
miR-155 expression
4ms
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. (PubMed, Blood Adv)
Importantly, MIR155HGΔexon3 human T cells retain GVL response significantly improving survival in an in vivo model of xeno-GVL. Altogether, we show that CRISPR/Cas9 mediated deletion of MIR155HG in primary human donor T cells is an innovative approach to generate allogeneic donor T cells that provide protection from lethal GVHD while maintaining robust anti-leukemic response.
Journal
|
MIR155 (MicroRNA 155)
|
miR-155 expression
4ms
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients. (PubMed, Front Oncol)
miRNAs are involved in PC tumorigenesis and metastatic spread. In light of miR-143 association with lymphatic spread and poor prognosis, a comprehensive analysis of miRNA interplay with KRAS deserves further investigation.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • MIR155 (MicroRNA 155) • MIR143 (MicroRNA 143) • MIR206 (MicroRNA 206)
|
KRAS mutation • miR-155 expression • miR-155 overexpression
5ms
Circulating microRNAs as novel biomarkers for measuring the potency of ginger extract against cyclophosphamide toxicity in rat renal tissues: molecular and histopathological study. (PubMed, Eur Rev Med Pharmacol Sci)
Treatment with ginger in rats induced with CP resulted in significant improvement in the expression of certain molecular miRNAs. The kidney tissues of these rats showed a marked decrease in the expression of miR-155-5p, miR-34a-5p, and miR-21-5p, while the levels of miR-193b-3p, miR-455-3p, and miR-342-3p were observed to increase significantly. In conclusion, ginger can protect rats from CP-induced nephrotoxicity.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • MIR155 (MicroRNA 155) • HMOX1 (Heme Oxygenase 1) • MIR21 (MicroRNA 21) • BAX (BCL2-associated X protein) • CASP3 (Caspase 3) • MIR34A (MicroRNA 34a-5p) • COL1A1 (Collagen Type I Alpha 1 Chain) • MIR193B (MicroRNA 193b) • MIR342 (MicroRNA 342) • MIR455 (MicroRNA 455)
|
BCL2 expression • miR-155 expression • BAX expression
|
cyclophosphamide
5ms
miR-155 facilitates the synergistic replication between avian leukosis virus subgroup J and reticuloendotheliosis virus by targeting a dual pathway. (PubMed, J Virol)
We observed that microRNA-155 targets a dual pathway, PRKCI-MAPK8 and TIMP3-MMP2, interacting with the U3 region of ALV-J and REV, enabling synergistic replication. This work gives us new targets to modulate ALV-J and REV's synergistic replication, guiding future research on the mechanism.
Journal
|
MIR155 (MicroRNA 155) • MMP2 (Matrix metallopeptidase 2) • MAPK8 (Mitogen-activated protein kinase 8) • TIMP3 (TIMP Metallopeptidase Inhibitor 3)
|
HAVCR2 expression • miR-155 expression
5ms
From inflammation to metastasis: The central role of miR-155 in modulating NF-κB in cancer. (PubMed, Pathol Res Pract)
It also emphasizes the miR-155's direct and indirect interactions with important NF-κB cascade elements to control the expression of NF-κB subunits. We also investigate how miR-155 affects NF-κB downstream effectors in cancer, including inflammatory cytokines and anti-apoptotic proteins.
Review • Journal
|
MIR155 (MicroRNA 155)
|
miR-155 expression
5ms
The biomarkers associated with epithelial-mesenchymal transition in human keloids. (PubMed, Burns)
In summary, this work provides novel EMT biomarkers in keloids and predicts new small target molecules for keloid therapy. Our findings improve the understanding of keloid pathogenesis, providing new treatment options.
Journal
|
MIR155 (MicroRNA 155) • CD24 (CD24 Molecule) • FN1 (Fibronectin 1) • EGF (Epidermal growth factor) • SOX9 (SRY-Box Transcription Factor 9) • CDH2 (Cadherin 2) • KRT19 (Keratin 19) • ITGB1 (Integrin Subunit Beta 1) • KRT18 (Keratin 18) • MIR124-2 (MicroRNA 124-2) • MIR145 (MicroRNA 145) • MIR20A (MicroRNA 20a) • MIRLET7B (MicroRNA Let-7b) • PROM1 (Prominin 1) • MIR124-3 (MicroRNA 124-3)
|
miR-155 expression • EPCAM expression
5ms
MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers. (PubMed, Biomarkers)
We conclude that miR-150 and miR-155 may be potentially applied as prognostic biomarkers in cervical cancer patients. However, further investigation is required to determine their applicability.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR223 (MicroRNA 223) • MIR150 (MicroRNA 150)
|
miR-155 expression • miR-146a expression
6ms
ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS. (PubMed, Exp Oncol)
miR-125b-2, -155, and -221 expres- sion can predict resistance to the letrozole treatment of BC.
Retrospective data • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • MIR155 (MicroRNA 155) • MIR221 (MicroRNA 221)
|
miR-155 expression • miR-125b-2 expression • miR-221 expression
|
letrozole
6ms
THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA. (PubMed, Exp Oncol)
The results indicate the relationship between miR-10b and -155 and the presence of lymph node metastases in OSCC patients, so these miRNAs can be considered as prognostic markers of the disease.
Journal
|
CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • MIR155 (MicroRNA 155) • MIR10B (MicroRNA 10b)
|
miR-155 expression • CDKN2A expression
6ms
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. (PubMed, J Cancer Res Clin Oncol)
Monocyte subsets differentiation in HCC was linked to hsa-miR-21-5p and hsa-miR-155-5p. Combined up-regulation of intermediate monocytes frequency and hsa-miR-21-5p expression could be considered a sensitive indicator of LC progression to HCC. Circulating intermediate monocytes and hsa-miR-21-5p were independent risk factors for HCC evolution, clinically and in silico proved.
Journal
|
MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21)
|
miR-155 expression • miR-21 expression
6ms
Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive Cells, Possibly through the Transfer of miRNA Cargo (ASH 2023)
Here, we highlight that the enriched expression of exosome pathway proteins reported in dara R cell lines is not detected in Lenalidomide or Bortezomib-resistant cell lines, or in other monoclonal antibody resistant cell lines such as anti-CD20 (Rituximab)-resistant cell lines, thus indicating that this mechanism is unique to daratumumab resistance...Next, we assessed the effect of inhibiting dara R EV secretion by applying Neticonazole and Ketoconazole, prior to coculture of resistant and sensitive cell lines...We are currently elucidating the biological basis for dara resistance mediated by these miRNAs. A deeper understanding of the mechanisms involved may pave the way for clinical evaluation of EV- directed therapeutics to overcome dara resistance.
IO biomarker
|
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1) • MIR155 (MicroRNA 155) • BACH1 (BTB Domain And CNC Homolog 1) • JARID2 (Jumonji And AT-Rich Interaction Domain Containing 2) • CD81 (CD81 Molecule) • MIR181A1 (MicroRNA 181a-1)
|
miR-155 expression
|
Rituxan (rituximab) • lenalidomide • bortezomib • Darzalex (daratumumab)
6ms
HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression. (PubMed, Viruses)
Genomic instability and the expression of PTEN, reported to act as an oncogene in mutp53-carrying cells such as BCPAP, also increased following HHV-6A-infection. These findings suggest that a ubiquitous herpesvirus such as HHV-6A, which displays a marked tropism for thyrocytes, could be involved in the progression of PTC towards more aggressive forms of thyroid tumor.
Journal
|
PTEN (Phosphatase and tensin homolog) • IL6 (Interleukin 6) • MIR155 (MicroRNA 155) • MIR221 (MicroRNA 221)
|
PTEN expression • miR-155 expression
6ms
Determination of T-Cell Clonality And Expression Profiles of Toll-Like Receptors Signaling Pathway genes and related miRNAs in Patients with Mycosis Fungoides. (PubMed, Gene)
TCR gamma clonal change analysis demonstrated that 55.5% of the analysed DNAs exhibited monoclonal and biallelic patterns, while 45.5% displayed polyclonality. These findings collectively suggest the potential influence and therapeutic possibilities of the TLR signalling pathway in the molecular pathogenesis of MF.
Journal • IO biomarker
|
MAP2K1 (Mitogen-activated protein kinase kinase 1) • MAP2K2 (Mitogen-activated protein kinase kinase 2) • MIR155 (MicroRNA 155) • CD4 (CD4 Molecule) • MIR21 (MicroRNA 21) • MIR210 (MicroRNA 210) • IRF7 (Interferon Regulatory Factor 7) • MIR130A (MicroRNA 130a) • MIRLET7E (MicroRNA Let-7e)
|
miR-155 expression
6ms
Prognostic impact of miR-125b and miR-155b and their relationship with MYC and TP53 in diffuse large B-cell lymphoma: cell-of-origin classification matters. (PubMed, J Clin Exp Hematop)
This study demonstrated different pathways based on cell-of-origin classification and highlighted different clinical outcomes. miR-125b, miR-155b and TP53 expression may also represent potential prognostic factors in nGC-DLBCL.
Journal • IO biomarker
|
TP53 (Tumor protein P53) • MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • BCL6 (B-cell CLL/lymphoma 6)
|
BCL2 expression • MYC expression • TP53 expression • miR-155 expression • BCL6 translocation
6ms
Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis. (PubMed, J Gastrointestin Liver Dis)
This study provides important insights regarding the molecular mechanisms underlying HCC progression in NAFLD patients, allowing for the development of better screening strategies for the early detection of NAFLD-associated HCC.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • MIR155 (MicroRNA 155) • MIR21 (MicroRNA 21) • MIR34A (MicroRNA 34a-5p) • MIR130A (MicroRNA 130a)
|
miR-155 expression
6ms
Overexpression of miR-146a and miR-155 are Potentially Biomarkers and Predict Unfavorable Relationship between Gastric Cancer and Helicobacter pylori Infection. (PubMed, Chonnam Med J)
In conclusion, H. pylori infection may increase the expression of miR-146a and miR-155 in patients with H. pylori and GC positive diagnoses, which can be effective in the curbing the progression of GC. For this reason, up-regulation of miR-146a and miR-155 along with H. pylori infection might contribute to the pathogenesis of GC, and also can be suggested as biomarkers for GC diagnosis and treatment.
Journal
|
MIR155 (MicroRNA 155)
|
miR-155 expression • miR-146a expression
7ms
Comparison of Plasma Levels of MicroRNA-155-5p, MicroRNA-210-3p, and MicroRNA-16-5p in Rheumatoid Arthritis Patients with Healthy Controls in a Case-control Study. (PubMed, Iran J Allergy Asthma Immunol)
Increased expressions of miR-16-5p and miR-155-5p and decreased expression of miR-210-3p in rheumatoid arthritis patients compared with healthy individuals demonstrate the effectiveness of these microRNAs in disease incidence and progression. Thus, the expression levels of these microRNAs can be used for diagnostic and therapeutic purposes.
Journal
|
MIR155 (MicroRNA 155) • MIR16 (MicroRNA 16) • MIR210 (MicroRNA 210)
|
miR-155 expression
7ms
Milk thistle nano-micelle formulation promotes cell cycle arrest and apoptosis in hepatocellular carcinoma cells through modulating miR-155-3p /SOCS2 /PHLDA1 signaling axis. (PubMed, BMC Complement Med Ther)
N-MT can regulate cancer cell death by arresting cell cycle and inducing apoptosis. This occurs through the alteration of apoptotic genes expression. A reduction in the expression of miR-155-3p and increase in the expression of SOCS2 and PHLDA1 after N-MT treatment showed the correlation between miR-155-3p and PHLDA1/SOCS2 found in bioinformatics analysis. While N-MT increased TP53 expression in HepG2, reduced it in Huh-7. The findings indicate that N-MT can function intelligently in cancer cells and can be a helpful complement to cancer treatment.
Journal • IO biomarker
|
TP53 (Tumor protein P53) • BCL2 (B-cell CLL/lymphoma 2) • MIR155 (MicroRNA 155) • BAX (BCL2-associated X protein) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • SOCS2 (Suppressor Of Cytokine Signaling 2)
|
TP53 mutation • TP53 wild-type • BCL2 expression • TP53 expression • miR-155 expression • SOCS2 expression